ABSTRACT
A cross-sectional study was made of the prevalence of HCV and associated risk factors in 382 multi-transfused patients and haemodialysis staff in Yadz province in 2006. Of those tested for anti-HCV antibodies, 50.6% of patients with inherited bleeding disorders, 11.8% with thalassaemia and 5.0% undergoing haemodialysis were seropositive. First transfusion before 1996 [when blood donor screening started] was the common risk factor associated with HCV infection. Only 1/52 haemodialysis staff members was HCV infected [an intravenous drug user]. Infection control measures were poor in all centres. In patients with inherited bleeding disorders genotype 1 [65.0%] was the predominant followed by genotype 3 [35.0%]. The results provide evidence that blood donor screening and use of virus-inactivated factor concentrates have lowered the risk of HCV infection among multi-transfused patients
Subject(s)
Humans , Male , Female , Blood Transfusion , Health Personnel , Hemodialysis Units, Hospital , Prevalence , Cross-Sectional Studies , Risk FactorsABSTRACT
Hepatitis A is a viral infection which is transmitted via fecal-oral route and its prevalence is directly related to the public health standards. The prevalence rate of this infection is different in different populations. The aim of this study was to determine the prevalence of hepatitis A antibody and assess the need for vaccination against hepatitis A in Tehran Province. This descriptive analytical cross-sectional study was conducted from 2006 to 2007 in Tehran Province. 448 subjects were selected by random cluster sampling. Blood samples were collected and demographic data were recorded in a questionnaire. Anti-HAV antibodies were measured by ELISA competitive method. Chi-square test and student t-test were used for statistical analysis. This study included 287 women and 161 men. Anti-HAV antibody was positive in 405 subjects [90.4%]. There were no significant relationships between HAV seropositivity and different age groups or gender. The results of our study showed a high prevalence of antibody in this region which is compatible with those of WHO results. Our results were similar to those obtained in Zabol City and eastern parts of Golestan Province but were not compatible with the results of the studies from Isfahan and Tabriz. At the present time there is no need for vaccination in this region
ABSTRACT
Inherited bleeding disorder is a disease due to deficiency in clotting factors or platelets. Replacement therapy of unscreened blood and blood products or unviricidal concentrated clotting factors would expose these patients to risk of acquired hepatitis C. The aim of this study was to determine the seroprevalence of hepatitis C virus and related risk factors among bleeding disorder patients in Yazd province. This cross-sectional study was performed in Yazd province in summer 2006 using census method. Following data collection through questionnaires, blood samples were taken from 77 [82.8%] patients. Plasma samples were tested for the presence of anti-HCV antibody via a third-generation ELISA kit. To exclude false positive cases, ELISA positive samples were re-tested by the confirmatory third generation RIBA test. The assessment of risk factors was done from the information analysis of both the questionnaires and test results by Chi-square test and multivariate logistic regression analysis, using SPSS 11.5 statistic software. The frequency of anti-HCV antibody was found in 38 [49.4%] patients. Chi-square test showed a statistically significant relationship between the severe form of the disease [in terms of blood products needed] [P<0.001], treatment duration of more than 121 months [P<0.001] and family history to HCV [P<0.05] antibody positivity. Successful execution of the screening of the blood and blood products as well as more scrutiny in preparing concentrated factors have been led to a remarkable decrease in the new infections among the recipients of these products in Yazd province